8 research outputs found
Kajian Pengobatan Dengue Haemoragic Fever (DHF) di Rumah Sakit Pendidikan Universitas Mataram
No full textDengue Hemorrhagic Fever (DHF) has become a worldwide problem. Dengue Haemoraggic Fever (DHF) is a disease caused by the dengue virus through the bite of the Aedes aegypti mosquito. DHF has a high mortality rate, so there is a need for appropriate therapy to reduce morbidity. This study aims to determine how the rationality of treatment in patients with Dangue Haemorraggic Fever (DHF) at the University Hospital of Mataram for the Period January - June 2020. This study is a non-experimental descriptive study, where data was taken retrospectively obtained from records. Medical records of Dengue Haemoraggic Fever (DHF) patients at the Inpatient Installation of Mataram University Hospital Period January - June 2020. The sampling technique used was purposive sampling, and 40 medical records were obtained. This research was conducted by looking at the rationality of treatment based on the right indication, the right patient, the right drug, and the right dose. The data obtained were compared with the basic guidelines for the management of DHF treatment therapy from the Ministry of Health of the Republic of Indonesia in 2004. The results showed the rationality of DHF treatment seen from several aspects, namely in the use of analgesic-antipyretic drugs and maintenance fluids, appropriate indications in the use of analgesic-antipyretic drugs and maintenance fluid obtained a percentage of 100%. In addition, the exact data on antipyretic analgesic drugs was 82.5%, the exact dose of antipyretic analgesics was 55
IMPLEMENTASI FARMAKOLOGI DALAM PRAKTIK KEBIDANAN
No full textIMPLEMENTASI FARMAKOLOGI DALAM PRAKTIK KEBIDANAN
Alyxia Gita Stellata, Mida Pratiwi, Iga Mayola Pisacha, Goldha Faroliu, Lilik Koernia Wahidah, Diah Kartika Putri, Fikriya Ridlawati, Nazhipah Isnani, Adzka Fahma Rodliya, Vicko Suswidiantoro, Dwi Aulia Ramdini, Rurynta Ferly Shavira, Ihsanti Dwi Rahayu, Nurma Suri, Yetri Darnas, Shinta Wulandari, Sutanto, Denih Agus Setia Permana, Suryadi Islami, Dwi Monika Ningrum, Muliyani, Ifah Yulistyani, Wina Safutri, Novita Tri Wahyuni, Nurfidini Azmi, Rasmi Zakiah Oktarlina, Ni Nyoman Trioka Rtamagustini, Ade Kurniawati, Niken Feladita, Nisa Yulianti Suprahman, Citra Yuliyanda Pardilawati, Ervina Damayanti, Sarmoko, Juwita Desri Ayu
ISBN: 978-623-93554-9-4
Tebal: xvii + 538 hlm., 21 x 15 cm | Juli 2023
Editor: Juwita Desri Ayu
Penata Letak: B. Achmad Elfatih
Penata Sampul: Echa Elsyah
Penerbit:
CV. AYRADA MANDIRI
Perumahan Griya Rumah Emas P 24
Jalan Poros Paccellekang, Gowa-Makassar
Sulawesi Selatan, 90562 Indonesia
Telp. 0411-210685, HP/WA 08999991135 Email: [email protected]
ANGGOTA IKAPI: No. 033/SSL/2021
Hak cipta dilindungi undang-undang
Dilarang memperbanyak isi buku ini dalam bentuk dan dengan cara apapun tanpa izin tertulis dari penerbit
IDENTIFIKASI ADVERSE DRUG REACTION PENGGUNAAN OBAT ANTI TUBERKULOSIS PARU DI UPTD PUSKESMAS KROYA I PERIODE JANUARI 2019 – DESEMBER 2020
No full textAdverse Adverse Drug Reaction (ADR) events are quite common, especially in TB patients, it is important for us to monitor ADR to ensure safety during treatment and improve patient quality of life considering the many types of drugs used and the long duration of treatment. The purpose of this study was to determine the identification of Adverse Drug Reactions from the Use of Anti Pulmonary Tuberculosis Drugs in the UPTD of the Kroya 1 Health Center for the period January 2019 - December 2020. This study used an observational method with a sample of 74 patients. The data in this study were obtained from medical record data according to the inclusion and exclusion criteria. The results showed that patients with pulmonary TB at the UPTD Kroya Health Center 1 Period January 2019 - December 2020 with the highest number of patients, namely the adult category or in the age range of 20-60 years as many as 52 patients (70.3%), male and female. male as many as 40 patients (54.1%), in 2019 the intensive stage was (32.4%), the advanced stage (13.5%) while in 2020 the intensive stage was (33.8%) and the advanced stage (20.3%) ). From this study, the results showed the number of patients with ADR in the form of nausea as many as 31 patients (39.2%), no appetite as many as 8 patients (10.1%), itching as many as 13 patients (16.5%), tingling in 10 patients ( 12,7%), joint pain in 7 patients (8,9%), and abdominal pain in 5 patients (6,3%) and 5 patients did not experience ADR (6.3%). There is a significant relationship between the stage of treatment with Adverse Drug Reaction with a value of 0.013. The conclusion was that an adverse drug reaction was identified on the use of anti-pulmonary tuberculosis drugs at the UPTD of the Kroya 1 Health Center for the 2019-2020 period
Gerakan Masyarakat Cerdas Menggunakan Hand Sanitizer Dan Masker Sebagai Upaya Preventif Terhadap Covid-19
No full textCovid-19 merupakan penyakit infeksi pernapasan akut yang disebabkan oleh corona virus strain severe acute respiratory syndrome corona virus 2 yang dapat dengan mudah menyebar dan ditularkan melalui jalur pernapasan penderita terinfeksi. Gejala Covid-19 umumnya berupa demam 38°C, batuk kering, dan sesak nafas serta dampak paling buruk untuk manusia ialah kematian yang dapat disebabkan oleh adanya penyakit penyerta seperti hipertensi diabetes mellitus, jantung koroner dan penyakit serebrovaskula. Masyarakat di sekitar kampus STIKES Al-Irsyad Al- Islamiyyah Cilacap masih terlihat belum terbiasa menggunakan masker pada saat keluar rumah. Kurangnya Upaya preventif saat di luar rumah dengan membawa handsanitizer dikarenakan persediaan dan harga dipasaran yang melambung tinggi (mahal) sehingga masyarakat mengalami kendala pada saat membelinya. Tujuan dari pengabdian masayarakat ini adalah untuk menciptakan Gerakan Masyarakat Cerdas Menggunakan Hand Sanitizer Dan Masker Sebagai Upaya Preventif Terhadap Covid-19. Metode pangabdian yaitu berupa donasi masker dan handsanitizer serta pemberian informasi pemakaiannya secara lisan. Hasil yang diperoleh adalah 120 orang sasaran sudah mendapatkan handsanitizer dan 120 orang mendapatkan masker diserati leaflet berkaitan dengan covid-19. Dengan demikian, masyarakat sekitar kampus dapat menggunakan masker dan perbekalan handsanitizer pada saat keluar rumah.
 
Studi Potensi Interaksi Obat Pasien Covid-19 di Rumah Sakit Umum Daerah Kota Mataram: Study on The Potential Drug Interactions in COVID-19 Patient at the Mataram City General Hospital
No full textCovid-19 or Coronavirus disease 2019 is an acute respiratory disease caused by the Severe Acute Respiratory Syndrom Coronavirus (SARS CoV-2), which entered Indonesia in early 2020. Data on Covid-19 in West Nusa Tenggara Province (NTB) in November reported 4,550 cases. Covid-19 can cause disorders in the respiratory system, acute pneumonia to death, so researchers conducted this study which aims to see how potential drug interactions exist in patients who get Covid-19 therapy while being treated at the Mataram City Hospital for the January-December 2021 period. This research is a descriptive study conducted to get an idea of whether there are potential drug interactions that occur by conducting research objectively. Data obtained from primary data, namely medical records of patients diagnosed with Covid-19 and treated in isolation rooms. Obtained as many as 95 medical record data of Covid-19 patients in the period January - December 2021. This research is a descriptive study conducted to get an idea of whether there are potential drug interactions that occur by conducting research objectively. Data obtained from primary data, namely medical records of patients diagnosed with Covid-19 and treated in isolation rooms. As many as 95 medical record data for Covid-19 patients were obtained in the period January – December 2021. Of the 95 patients obtained, it was found that the category of drug interactions with drugs based on severity was 5.26%, moderate interactions were 42.10%, and major interactions were 3.15%. The conclusion of this study is that the most common potential drug interactions were found with moderate severity with a percentage of 42.10% of 95 patients.
ABSTRAK
Covid-19 atau Coronavirus disease 2019 merupakan suatu penyakit pernapasan akut yang disebabkan oleh Severe Acute Respiratory Syndrom Coronavirus (SARS CoV-2), yang masuk ke Indonesia di awal tahun 2020. Data Covid-19 di Provinsi Nusa Tenggara Barat (NTB) pada bulan November dilaporkan sebanyak 4.550 kasus. Covid-19 dapat menyebakan gangguan pada sistem pernapasan, pneumonia akut hingga kematian, sehingga peneliti melakukan penelitian ini yang bertujuan untuk melihat bagaimana potensi adanya interaksi obat pada pasien yang mendapatkan terapi Covid-19 selama di rawat di RSUD Kota Mataram periode Januari-Desember 2021. Penelitian ini merupakan penelitian deskriptif yang dilakukan untuk mendapatkan gambaran apakah ada potensi interaksi obat yang terjadi dengan melakukan penelitian secara objektif. Data diperoleh dari data primer yaitu rekam medis pasien yang terdiagnosa Covid-19 dan dirawat di ruang isolasi. Diperoleh sebanyak 95 data rekam medis pasien Covid-19 pada periode Januari – Desember 2021. Dari 95 pasien yang diperoleh, ditemukan diperoleh kategori interaksi obat dengan obat berdasarkan keparahan yaitu interaksi minor sebanyak 5,26% , interaksi moderate 42,10% , dan interaksi mayor sebanyak 3,15%. Kesimpulan penelitian ini adalah potensi interaksi obat yang paling banyak ditemukan yaitu dengan tingkat keparahan moderate dengan persentase sebesar yaitu 42,10% dari 95 pasien
PROFIL PENGOBATANPASIEN GERIATRI DIABETES MELITUS DENGAN PENYAKIT PENYERTA DI INSTALASI FARMASI RAWAT JALAN RS PKU MUHAMMADIYAH SRUWENG
No full textDiabetes melitus (DM) merupakan suatu gangguan metabolisme yang terjadi pada organ pankreas yang ditandai dengan adanya peningkatan kadar gula darah. DM adalah masalah kesehatan global dimana morbiditas, komplikasi dan mortalitas lebih tinggi pada populasi lansia dibandingkan kelompok yang lebih muda. Pada pasien geriatri diabetes melitus, biasanya ditemukan lebih dari satu penyakit kronik sehingga pasien akan menerima lebih dari satu jenis obat yang akan meningkatkan potensi kejadian interaksi obat. Tujuan dari penelitian ini yaitu untuk mengetahui interaksi obat pada pasien geriatri diabetes melitus dengan penyakit penyerta di Instalasi Farmasi Rawat Jalan RS PKU Muhammadiyah Sruweng. Jenis penelitian adalah non eksperimental yang dilakukan secara deskriptif dengan pengambilan data secara restrospektif. Pengambilan data dilakukan berdasarkan data rekam medik pasien geriatri diabetes melitus dengan penyakit penyerta bulan Juni - Agustus 2023 dan ditinjau interaksi obatnya berdasarkan aplikasi Lexicomp. Dari 182 sampel pasien geriatri diabetes melitus dengan penyakit penyerta, sebanyak 172 pasien (94,51%) mengalami interaksi obat dengan total kejadian 721 kasus. Mekanisme interaksi obat paling banyak terjadi pada mekanisme farmakokinetik dengan 410 kasus (56,87%). Tingkat keparahan dari interaksi obat paling tinggi yang terjadi pada tingkat moderat dengan total kejadian 559 kasus (77,21%)
Diabetes mellitus in society: Increasing public awareness through a social approach
No full textDiabetes mellitus (DM) is a non-communicable disease with high morbidity and mortality. Lifestyle and knowledge are crucial factors in the handling and prevention of DM, but public awareness to obtain information is still low. This activity was carried out to increase public awareness in obtaining information and providing education related to DM. Preparation for the activity was carried out from 21 November 2022 and the core activities were in the form of outreach and health checks as a DM screening and were carried out on 24 November 2022. The main target for this activity were residents who had a family history of suffering from DM and risk factors such as obesity and hypertension. From this activity it was found that 90% had high blood pressure and 2 of them had fasting blood sugar levels above 300 mg/dL. In addition, it is known that public awareness to obtain information is still lacking
Peningkatan Kualitas dan Marketing Produk Makanan Khas Cilacap Berbasis SDA Bahari Kelompok UMKM Mina Rasa
No full textKelompok UMKM Mina Rasa merupakan pelaku usaha mikro di Cilacap pada produksi makanan olahan berbasis SDA Bahari. Produk yang dihasilkan meliputi abon tuna, sambal, kerupuk tenggiri, ikan jambrong, ikan jambal, serta olahan laut lainnya. Prinsip produksi sehat tanpa bahan pengawet kimia menjadi identitas utama. Namun, usaha ini menghadapi tantangan besar akibat perubahan tren pasar digital, meningkatnya persaingan produk sejenis, serta daya beli konsumen yang melemah. Kendala lain adalah masa simpan produk yang hanya bertahan 3 bulan, sederhana dalam pengemasan, dan terbatasnya peralatan sterilisasi, sehingga distribusi produk menjadi terhambat. Program ini hadir sebagai solusi pada inovasi teknologi dan pemasaran. Upaya dimulai dari pembuatan pengawet alami nanochitomin, uji produk, penerapan metode sterilisasi uap, hingga penggunaan sistem vacuum untuk memperpanjang umur simpan. Inovasi pengawetan alami berbasis nanochitomin dari limbah kulit udang merupakan pendekatan baru yang belum diterapkan sebelumnya di UMKM lokal Cilacap, di mana teknologi ini mampu meningkatkan ketahanan produk, menjaga kualitas gizi, serta mendukung prinsip ramah lingkungan melalui pemanfaatan limbah perikanan. Selanjutnya, dilakukan perbaikan desain kemasan agar lebih menarik. Pada aspek pemasaran, pendampingan diberikan melalui sosialisasi digital marketing, pengelolaan media sosial, serta strategi penjualan online di marketplace. Hasil kegiatan menunjukkan bahwa pengetahuan peserta meningkat 55% setelah pelatihan berdasarkan hasil pre-post test. Melalui kegiatan ini, UMKM Mina Rasa diharapkan mampu meningkatkan kualitas produk, memperluas pasar, serta memperkuat posisi sebagai representasi kuliner khas bahari Cilacap yang inovatif, berdaya saing, dan berkelanjutan.
Quality Improvement and Marketing of Cilacap’s Local Food Products Based on Marine Resources by UMKM Mina Rasa
Abstract
The Mina Rasa MSME Group is a micro-enterprise in Cilacap in the production of processed foods based on marine natural resources. The products produced include tuna floss, chili sauce, tenggiri crackers, jambrong fish, jambal fish, and other seafood products. The principle of healthy production without chemical preservatives is the main identity. However, this business faces major challenges due to changes in digital market trends, increasing competition from similar products, and weakening consumer purchasing power. Other obstacles are the product's shelf life which only lasts 3 months, simple packaging, and limited sterilization equipment, so that product distribution is hampered. This program is presented as a solution to technological and marketing innovation. Efforts start from the manufacture of natural preservative nanochitomin, product testing, application of steam sterilization methods, to the use of a vacuum system to extend shelf life. The innovation of natural preservatives based on nanochitomin from shrimp shell waste is a new approach that has not been implemented before in local MSMEs in Cilacap, where this technology is able to increase product durability, maintain nutritional quality, and support environmentally friendly principles through the utilization of fishery waste. Furthermore, improvements to the packaging design are made to make it more attractive. In terms of marketing, mentoring was provided through digital marketing outreach, social media management, and online sales strategies in marketplaces. The training resulted in a 55% increase in participants' knowledge after the training, based on pre-posttest results. Through this activity, Mina Rasa MSME is expected to improve product quality, expand its market, and strengthen its position as a representative of Cilacap's innovative, competitive, and sustainable maritime culinary specialties.Kelompok UMKM Mina Rasa merupakan pelaku usaha mikro di Cilacap pada produksi makanan olahan berbasis SDA Bahari. Produk yang dihasilkan meliputi abon tuna, sambal, kerupuk tenggiri, ikan jambrong, ikan jambal, serta olahan laut lainnya. Prinsip produksi sehat tanpa bahan pengawet kimia menjadi identitas utama. Namun, usaha ini menghadapi tantangan besar akibat perubahan tren pasar digital, meningkatnya persaingan produk sejenis, serta daya beli konsumen yang melemah. Kendala lain adalah masa simpan produk yang hanya bertahan 3 bulan, sederhana dalam pengemasan, dan terbatasnya peralatan sterilisasi, sehingga distribusi produk menjadi terhambat. Program ini hadir sebagai solusi pada inovasi teknologi dan pemasaran. Upaya dimulai dari pembuatan pengawet alami nanochitomin, uji produk, penerapan metode sterilisasi uap, hingga penggunaan sistem vacuum untuk memperpanjang umur simpan. Selanjutnya, dilakukan perbaikan desain kemasan agar lebih menarik. Pada aspek pemasaran, pendampingan diberikan melalui sosialisasi digital marketing, pengelolaan media sosial, serta strategi penjualan online di marketplace. Melalui kegiatan ini, UMKM Mina Rasa diharapkan mampu meningkatkan kualitas produk, memperluas pasar, dan memperkuat posisi sebagai representasi kuliner khas bahari Cilaca
